Related Experiment Video

Updated: Sep 27, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

Behavioral medicine in the prevention and treatment of cardiovascular disease

Kristi D Graves1, Peter M Miller

  • 1Medical University of South Carolina, USA.

Behavior Modification
|February 18, 2003
PubMed

Insights

Cardiac behavioral medicine uses behavioral science to prevent and treat heart disease. Interventions improve outcomes by addressing lifestyle and psychosocial risk factors, enhancing patient compliance.

Area of Science:

  • Cardiology
  • Behavioral Medicine
  • Psychosocial Health

Background:

  • Cardiovascular disease necessitates addressing both biomedical and lifestyle risk factors.
  • Behavioral medicine integrates psychosocial principles into cardiac care.
  • Risk factors include high blood lipids, hypertension, diabetes, obesity, smoking, and inactivity.

Purpose of the Study:

  • To highlight the role of behavioral medicine in cardiovascular disease prevention and treatment.
  • To emphasize the importance of assessing and intervening in behavioral and psychosocial risk factors.
  • To review the benefits of behavioral interventions on cardiac outcomes.

Main Methods:

  • Application of behavioral and psychosocial principles.
  • Screening and intervention for behavioral and psychosocial risk factors (e.g., depression, hostility, social isolation).
  • Assessment of biomedical risk factors requiring lifestyle change (e.g., obesity, smoking, inactivity).

Main Results:

  • Behavioral interventions are crucial for managing biomedical cardiovascular risk factors.
  • Lifestyle changes are essential for risks like obesity, smoking, and inactivity.
  • Interventions improve cardiac outcomes by enhancing adherence to medical and lifestyle recommendations.

Conclusions:

  • Behavioral medicine is vital for preventing heart disease and improving outcomes in patients.
  • Assessment and intervention in behavioral and psychosocial factors are key to reducing morbidity and mortality.
  • Future research should focus on diverse populations and integration with new medical technologies.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...